Showing 15 posts of 94 posts found.


Roche withdraws Tecentriq combo application in first-line renal cell carcinoma

November 19, 2018
Sales and Marketing Cancer, Roche, avastin, pharma, renal cell carcinoma, tecentriq

The EMA has revealed that Roche has chosen to withdraw its marketing application for immunotherapy Tecentriq (atezolizumab) in combination with …

Bayer image

Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug

October 16, 2018
Manufacturing and Production Bayer, CCG, NHS, Novartis, avastin, wet AMD

Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning …

Courts back NHS in fight against Novartis and Bayer

September 24, 2018
Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

Roche unveils strong combination treatment data in lung cancer

November 20, 2017
Research and Development, Sales and Marketing Cancer, NSCLC< lung cancer, Roche, avastin, immunotherapy, pharma, tecentriq

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …

FDA approves first-ever biosimilar for cancer treatment

September 15, 2017
Medical Communications, Sales and Marketing Amgen, Cancer, FDA, Mvasi, avastin, biosimilar

The FDA has announced the news that it has awarded approval to the first-ever biosimilar for the treatment of cancer …


Tesaro’s ovarian cancer drug success threatens market rivals

October 12, 2016
Research and Development AbbVie, AstraZeneca, Pfizer, Roche, Tesaro, avastin, lynparza, niraparib, talazoparib, veliparib

Phase III results from Tesaro’s niraparib PARP inhibitor could spell trouble for rivals Roche and AstraZeneca as its showed sizeable …

Roche says combination therapy with its Avastin and Tarceva gets European backing for lung cancer treatment

June 8, 2016
Research and Development, Sales and Marketing European Commission, NSCL, RegulationC, Roche, Tarceva, avastin, drug trial, lung cancer

Cancer drugmaker Roche (SIX: ROG) on Wednesday said the European Commission has approved its Avastin (bevacizumab) in combination with Tarceva …


Roche beats estimates with strong 2015 sales

January 28, 2016
Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin

Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …


Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …


New treatment option for ovarian cancer patients in Scotland

September 8, 2015
Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …

Roche image

Roche buoyed by cancer drug sales

April 22, 2015
Sales and Marketing Actemra, Cancer, Esbriet, Esbriet., MabThera, Q1, Rituxan, RoActemra, Roche, Xolair, avastin, oncology

Pharma’s biggest cancer drugs maker Roche has reported strong sales growth on the back of its oncology portfolio for its …

Avastin image

EU nod for Roche cancer drug and chemotherapy

April 8, 2015
Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …

Lucentis image

Novartis accused of Lucentis ‘campaign’ against Avastin

April 2, 2015
Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD

Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

Roche image

Roche oncology sales shine but profits dip

January 29, 2015
Sales and Marketing Kadcyla, Perjeta, Roche, avastin, fourth quarter, oncology, q4

Roche has posted a mixed bag of financial results complemented only by strong growth in its oncology and immunology divisions. …


Government rips up blank cheque on cancer drugs

August 28, 2014
Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi

Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …

Latest content